|
|
Home | Search | Advance Search | Browse | Online Submission | Documentation & FAQ | Team | Contact us |
|
PolysacDB ID | 1002 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A linear (1-->3)-linked mannan backbone singly substituted with nonreducing β(1-->2) xylose and β(1-->2) glucuronic acid side branches ; O-acetyl groups are present at C-6 of the mannosyl residues |
BCSDB Structure | 130362 |
Proposed functions | Antiphagocytic ; an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates. |
Carrier Name | Tetanus toxoid |
Conjugation Method | GXM was derivatized by the following two methods. (i) In method 1, ADH [adipic acid dihydrazide] was introduced into GXM by the activation of carboxyl groups with EDAC. GXM (5 mg/ml of 0.2 M NaCl) was derivatized with 0.5 M ADH and 0.1 M EDAC at pH 4.85 for 3.5 h at room temperature, using a pH Stat. After extensive dialysis against 0.2 M NaCl, the reaction mixture was passed through a 2B-CL Sepharose column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The fractions containing GXM were pooled and concentrated to the original volume. (ii) In method 2, ADH was introduced into GXM by the activation of hydroxyl groups with CNBr. GXM (5 mg/ml of 0.2 M NaCl) was activated with an equal weight of CNBr at pH 10.5 for 6 min at 4°C, using a pH Stat. An equal volume of 0.5 M NaHCO3 (pH 8.5) containing 0.5 M ADH was added. The reaction mixture was tumbled at 3 to 8°C for 18 to 20 h, dialyzed against 0.2 M NaCl, and passed through a 2B-CL Sepharose column (1.5 by 30 cm). The fractions containing GXM were pooled and concentrated to the original volume. The reaction mixture, containing equal concentrations (3.0 to 7.5 mg/ml) of GXM-AH (derivatized by either method) and TT or rEPA in 0.2 M NaCl, was brought to pH 5.6 with 0.05 N HCl, and 0.05 to 0.1 M EDAC was added; the pH was maintained at 5.6 in a pH Stat for 1 to 3 h at 4°C. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a Sepharose 2B-CL column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The void volume fractions containing the GXM and the protein were pooled and stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Mab 2E9 |
Antibody type and class | IgM |
Assay System | ELISA |
Cross-reactivity | This antibody cross-reacted with Serotype A, B and D |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | Human glucurunoxylomannan monoclonal antibodies are essential to address questions regarding the role of glucurunoxylomannan antibodies in protection against cryptococcal infections |
Curator ID | AA + AS |
Date of Curation | 01-01-2010 |
References | PMC173409 |
PolysacDB ID | 1006 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A linear (1-->3)-linked mannan backbone singly substituted with nonreducing β(1-->2) xylose and β(1-->2) glucuronic acid side branches ; O-acetyl groups are present at C-6 of the mannosyl residues |
BCSDB Structure | 130362 |
Proposed functions | Antiphagocytic ; an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Tetanus toxoid |
Conjugation Method | GXM was derivatized by the following two methods. (i) In method 1, ADH [adipic acid dihydrazide] was introduced into GXM by the activation of carboxyl groups with EDAC. GXM (5 mg/ml of 0.2 M NaCl) was derivatized with 0.5 M ADH and 0.1 M EDAC at pH 4.85 for 3.5 h at room temperature, using a pH Stat. After extensive dialysis against 0.2 M NaCl, the reaction mixture was passed through a 2B-CL Sepharose column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The fractions containing GXM were pooled and concentrated to the original volume. (ii) In method 2, ADH was introduced into GXM by the activation of hydroxyl groups with CNBr. GXM (5 mg/ml of 0.2 M NaCl) was activated with an equal weight of CNBr at pH 10.5 for 6 min at 4°C, using a pH Stat. An equal volume of 0.5 M NaHCO3 (pH 8.5) containing 0.5 M ADH was added. The reaction mixture was tumbled at 3 to 8°C for 18 to 20 h, dialyzed against 0.2 M NaCl, and passed through a 2B-CL Sepharose column (1.5 by 30 cm). The fractions containing GXM were pooled and concentrated to the original volume. The reaction mixture, containing equal concentrations (3.0 to 7.5 mg/ml) of GXM-AH (derivatized by either method) and TT or rEPA in 0.2 M NaCl, was brought to pH 5.6 with 0.05 N HCl, and 0.05 to 0.1 M EDAC was added; the pH was maintained at 5.6 in a pH Stat for 1 to 3 h at 4°C. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a Sepharose 2B-CL column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The void volume fractions containing the GXM and the protein were pooled and stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Mab 3B6 |
Antibody type and class | IgM |
Assay System | ELISA |
Cross-reactivity | This antibody cross-reacted with Serotypes A, B, C and D |
Proposed epitopes | N\A |
IEDB Epitope | N/A |
Proposed Utility | Human glucurunoxylomannan monoclonal antibodies are essential to address questions regarding the role of glucurunoxylomannan antibodies in protection against cryptococcal infections |
Curator ID | AA + AS |
Date of Curation | 02-01-2010 |
References | PMC173409 |
PolysacDB ID | 1016 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The capsular polysaccharide has a linear α-(1-->3)-linked mannose backbone that is substituted with nonreducing D-xylosyl and D-glucuronosyl acid groups. The mannose backbone is partially O-acetylated |
BCSDB Structure | 113471 |
Proposed functions | The capsular polysaccharide is an important virulence factor |
Antigenic Nature used to produce antibodies | Cryptococci cells |
Carrier Name | N/A |
Conjugation Method | N/A |
Antibodies | Mab 21D2 |
Antibody type and class | IgM |
Assay System | ELISA |
Cross-reactivity | This antibody cross-reacted with Serotype A, D and GH strain |
Proposed epitopes | N\A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was shown to bind to cryptococcal capsule |
Curator ID | AA + AS |
Date of Curation | 05-01-2010 |
References | PMC2118886 |
PolysacDB ID | 1017 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The capsular polysaccharide has a linear α-(1-->3)-linked mannose backbone that is substituted with nonreducing D-xylosyl and D-glucuronosyl acid groups. The mannose backbone is partially O-acetylated |
BCSDB Structure | 113471 |
Proposed functions | The capsular polysaccharide is an important virulence factor |
Antigenic Nature used to produce antibodies | Cryptococci cells |
Carrier Name | N/A |
Conjugation Method | N/A |
Antibodies | Mab 14A12 |
Antibody type and class | IgM |
Assay System | ELISA |
Cross-reactivity | This antibody was specific to D serotype and cross-reacted with GH strain |
Proposed epitopes | N\A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was shown to bind to cryptococcal capsule |
Curator ID | AA + AS |
Date of Curation | 05-01-2010 |
References | PMC2118886 |
PolysacDB ID | 1018 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The capsular polysaccharide has a linear α-(1-->3)-linked mannose backbone that is substituted with nonreducing D-xylosyl and D-glucuronosyl acid groups. The mannose backbone is partially O-acetylated |
BCSDB Structure | 113471 |
Proposed functions | The capsular polysaccharide is an important virulence factor |
Antigenic Nature used to produce antibodies | Cryptococci cells |
Carrier Name | N/A |
Conjugation Method | N/A |
Antibodies | Mab 11E2 |
Antibody type and class | IgM |
Assay System | ELISA |
Cross-reactivity | This antibody was specific to D serotype and cross-reacted with GH strain |
Proposed epitopes | N\A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was shown to bind to cryptococcal capsule |
Curator ID | AA + AS |
Date of Curation | 05-01-2010 |
References | PMC2118886 |
PolysacDB ID | 1019 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The capsular polysaccharide has a linear α-(1-->3)-linked mannose backbone that is substituted with nonreducing D-xylosyl and D-glucuronosyl acid groups. The mannose backbone is partially O-acetylated |
BCSDB Structure | 113471 |
Proposed functions | The capsular polysaccharide is an important virulence factor |
Antigenic Nature used to produce antibodies | Cryptococci cells |
Carrier Name | N/A |
Conjugation Method | N/A |
Antibodies | Mab 7B13 |
Antibody type and class | IgM |
Assay System | ELISA |
Cross-reactivity | This antibody was specific to D serotype and cross-reacted with GH strain |
Proposed epitopes | N\A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was shown to bind to cryptococcal capsule |
Curator ID | AA + AS |
Date of Curation | 05-01-2010 |
References | PMC2118886 |
PolysacDB ID | 1020 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The capsular polysaccharide has a linear α-(1-->3)-linked mannose backbone that is substituted with nonreducing D-xylosyl and D-glucuronosyl acid groups. The mannose backbone is partially O-acetylated |
BCSDB Structure | 113471 |
Proposed functions | The capsular polysaccharide is an important virulence factor |
Antigenic Nature used to produce antibodies | Cryptococci cells |
Carrier Name | N/A |
Conjugation Method | N/A |
Antibodies | Mab 12G5 |
Antibody type and class | IgM |
Assay System | ELISA |
Cross-reactivity | This antibody was specific to D serotype and cross-reacted with GH strain |
Proposed epitopes | N\A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was shown to bind to cryptococcal capsule |
Curator ID | AA + AS |
Date of Curation | 06-01-2010 |
References | PMC2118886 |
PolysacDB ID | 1021 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The capsular polysaccharide has a linear α-(1-->3)-linked mannose backbone that is substituted with nonreducing D-xylosyl and D-glucuronosyl acid groups. The mannose backbone is partially O-acetylated |
BCSDB Structure | 113471 |
Proposed functions | The capsular polysaccharide is an important virulence factor |
Antigenic Nature used to produce antibodies | Cryptococci cells |
Carrier Name | N/A |
Conjugation Method | N/A |
Antibodies | Mab 20C5 |
Antibody type and class | IgM |
Assay System | ELISA |
Cross-reactivity | This antibody was specific to D serotype and cross-reacted with GH strain |
Proposed epitopes | N\A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was shown to bind to cryptococcal capsule |
Curator ID | AA + AS |
Date of Curation | 06-01-2010 |
References | PMC2118886 |
PolysacDB ID | 1022 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The capsular polysaccharide has a linear α-(1-->3)-linked mannose backbone that is substituted with nonreducing D-xylosyl and D-glucuronosyl acid groups. The mannose backbone is partially O-acetylated |
BCSDB Structure | 113471 |
Proposed functions | The capsular polysaccharide is an important virulence factor |
Antigenic Nature used to produce antibodies | Cryptococci cells |
Carrier Name | N/A |
Conjugation Method | N/A |
Antibodies | Mab 20B5 |
Antibody type and class | IgM |
Assay System | ELISA |
Cross-reactivity | This antibody was specific to D serotype and cross-reacted with GH strain |
Proposed epitopes | N\A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was shown to bind to cryptococcal capsule |
Curator ID | AA + AS |
Date of Curation | 06-01-2010 |
References | PMC2118886 |
PolysacDB ID | 1023 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The capsular polysaccharide has a linear α-(1-->3)-linked mannose backbone that is substituted with nonreducing D-xylosyl and D-glucuronosyl acid groups. The mannose backbone is partially O-acetylated |
BCSDB Structure | 113471 |
Proposed functions | The capsular polysaccharide is an important virulence factor |
Antigenic Nature used to produce antibodies | Cryptococci cells |
Carrier Name | N/A |
Conjugation Method | N/A |
Antibodies | Mab 4H3 |
Antibody type and class | IgG3 |
Assay System | ELISA |
Cross-reactivity | This antibody was specific to D serotype and cross-reacted with GH strain |
Proposed epitopes | N\A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was shown to bind to cryptococcal capsule |
Curator ID | AA + AS |
Date of Curation | 07-01-2010 |
References | PMC2118886 |
PolysacDB ID | 1024 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The capsular polysaccharide has a linear α-(1-->3)-linked mannose backbone that is substituted with nonreducing D-xylosyl and D-glucuronosyl acid groups. The mannose backbone is partially O-acetylated |
BCSDB Structure | 113471 |
Proposed functions | The capsular polysaccharide is an important virulence factor |
Antigenic Nature used to produce antibodies | Cryptococci cells |
Carrier Name | N/A |
Conjugation Method | N/A |
Antibodies | Mab 15C6 |
Antibody type and class | IgA |
Assay System | Immunofluorescence |
Cross-reactivity | This antibody was specific to D serotype and cross-reacted with GH strain |
Proposed epitopes | N\A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was shown to bind to cryptococcal capsule |
Curator ID | AA + AS |
Date of Curation | 07-01-2010 |
References | PMC2118886 |
PolysacDB ID | 1025 |
Carbohydrate Name | Capsular polysaccharide A (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The capsular polysaccharide has a linear α-(1-->3)-linked mannose backbone that is substituted with nonreducing D-xylosyl and D-glucuronosyl acid groups. The mannose backbone is partially O-acetylated |
BCSDB Structure | N/A |
Proposed functions | The capsular polysaccharide is an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Sheep erythrocytes |
Conjugation Method | The capsular polysaccharide was adsorbed with 0.1 ml of packed sheep erythrocytes for 2 hours at room temperature |
Antibodies | Mab 439 |
Antibody type and class | IgG1 |
Assay System | Ouchterlony double immunodiffusion, Phagocytosis assays |
Cross-reactivity | This antibody cross-reacted with all the 4 serotypes- A, B, C and D |
Proposed epitopes | The reactivity of this antibody required an intact carboxyl group and also required deacetylation of the parent polysaccharide |
IEDB Epitope | N/A |
Proposed Utility | MAb against an epitope shared by all four serotypes may have value for the detection of cryptococcal antigens in body fluids. This antibody also has potent opsonic activity |
Curator ID | AA + AS |
Date of Curation | 07-01-2010 |
References | PMC260621 |
PolysacDB ID | 1026 |
Carbohydrate Name | Capsular polysaccharide A (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The capsular polysaccharide has a linear α-(1-->3)-linked mannose backbone that is substituted with nonreducing D-xylosyl and D-glucuronosyl acid groups. The mannose backbone is partially O-acetylated |
BCSDB Structure | N/A |
Proposed functions | The capsular polysaccharide is an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Sheep erythrocytes |
Conjugation Method | The capsular polysaccharide was adsorbed with 0.1 ml of packed sheep erythrocytes for 2 hours at room temperature |
Antibodies | Mab 1255 |
Antibody type and class | IgG1 |
Assay System | Ouchterlony double immunodiffusion, Phagocytosis assays |
Cross-reactivity | This antibody cross-reacted with 3 serotypes- A, B and D |
Proposed epitopes | The reactivity of this antibody required an intact carboxyl group and also required deacetylation of the parent polysaccharide |
IEDB Epitope | N/A |
Proposed Utility | MAb against an epitope shared by all four serotypes may have value for the detection of cryptococcal antigens in body fluids. This antibody also has potent opsonic activity |
Curator ID | AA + AS |
Date of Curation | 08-01-2010 |
References | PMC260621 |
PolysacDB ID | 1027 |
Carbohydrate Name | Capsular polysaccharide D (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The capsular polysaccharide has a linear α-(1-->3)-linked mannose backbone that is substituted with nonreducing D-xylosyl and D-glucuronosyl acid groups. The mannose backbone is partially O-acetylated |
BCSDB Structure | N/A |
Proposed functions | The capsular polysaccharide is an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Sheep erythrocytes |
Conjugation Method | The capsular polysaccharide was adsorbed with 0.1 ml of packed sheep erythrocytes for 2 hours at room temperature |
Antibodies | Mab 302 |
Antibody type and class | IgG1 |
Assay System | Ouchterlony double immunodiffusion, Phagocytosis assays |
Cross-reactivity | This antibody cross-reacted with 2 serotypes- A and D |
Proposed epitopes | The reactivity of this antibody required acetylation of the parent polysaccharide. Hence proposed epitopes may be O-acetyl groups |
IEDB Epitope | N/A |
Proposed Utility | MAb against an epitope shared by all four serotypes may have value for the detection of cryptococcal antigens in body fluids. This antibody also has potent opsonic activity |
Curator ID | AA + AS |
Date of Curation | 08-01-2010 |
References | PMC260621 |
PolysacDB ID | 1028 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The GXM is a high-molecular-weight linear (1-->3)-α-D-mannan substituted with single (1-->2)-β-xylosyl and (1-->2)-β-glucuronosyl residues. 0 acetylation occurs on the C-6 of about half of the mannose residues. The molar ratio of xylose-mannose-glucuronic acid is 2:3:1 for serotype A |
BCSDB Structure | 130362 |
Proposed functions | The capsular glucuronoxylomannan (GXM) of C. neoformans is anantiphagocytic and tolerogenic polysaccharide and potentiates virulence |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Bovine serum albumin |
Conjugation Method | GXM (100 mg) was suspended in acetone, and 75 ul of pyridine was added. Tresyl chloride (50 ,ul) was added and stirred for 10 min. The activated GXM was washed with ethanol containing 5 mM HCI, washed with absolute ethanol, and dried in vacuo. Activated GXM (46 mg) was dissolved in 1.5 ml of 0.2 M NaH2PO4 buffer (pH 7.5) (coupling buffer), and BSA-AH was added (25 mg in 0.5 ml of the same buffer). The reaction was stirred overnight at 24°C. The precipitate was removed by centrifugation, and the supernatant was applied to a column (90 by 2.5 cm) of Sepharose CL-6B equilibrated with 0.05 M Tris hydrochloride-0.1 M NaCl buffer (pH 7.6). The flow rate was 35 ml/h. Fractions containing carbohydrate and protein appeared in the void volume. They were pooled, dialyzed, and lyophilized (yield, 33 mg). The conjugate was then rechromatographed [yield, 17 mg] |
Antibodies | Mab BD1 |
Antibody type and class | IgG1 |
Assay System | Indirect immunofluorescence |
Cross-reactivity | This antibody cross-reacted with 2 serotypes- A and D. BD-1 also showed some cross-reactions at a low dilution with B. dermatitidis and H. capsulatum and C. terreus |
Proposed epitopes | Glucuronic acid was proposed to be the important constituent of the epitope. However the epitope also probably contained xylose and was influencedto a minor extent by the presence of O-acetyl groups |
IEDB Epitope | N/A |
Proposed Utility | MAb against an epitope shared by all four serotypes may have value for the detection of cryptococcal antigens in body fluids. This antibody also has potent opsonic activity |
Curator ID | AA + AS |
Date of Curation | 08-01-2010 |
References | PMC259921 |
PolysacDB ID | 1029 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The GXM is a high-molecular-weight linear (1-->3)-α-D-mannan substituted with single (1-->2)-β-xylosyl and (1-->2)-β-glucuronosyl residues. 0 acetylation occurs on the C-6 of about half of the mannose residues. The molar ratio of xylose-mannose-glucuronic acid is 2:3:1 for serotype A |
BCSDB Structure | 130362 |
Proposed functions | The capsular glucuronoxylomannan (GXM) of C. neoformans is anantiphagocytic and tolerogenic polysaccharide and potentiates virulence |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Bovine serum albumin |
Conjugation Method | GXM (100 mg) was suspended in acetone, and 75 ul of pyridine was added. Tresyl chloride (50 ,ul) was added and stirred for 10 min. The activated GXM was washed with ethanol containing 5 mM HCI, washed with absolute ethanol, and dried in vacuo. Activated GXM (46 mg) was dissolved in 1.5 ml of 0.2 M NaH2PO4 buffer (pH 7.5) (coupling buffer), and BSA-AH was added (25 mg in 0.5 ml of the same buffer). The reaction was stirred overnight at 24°C. The precipitate was removed by centrifugation, and the supernatant was applied to a column (90 by 2.5 cm) of Sepharose CL-6B equilibrated with 0.05 M Tris hydrochloride-0.1 M NaCl buffer (pH 7.6). The flow rate was 35 ml/h. Fractions containing carbohydrate and protein appeared in the void volume. They were pooled, dialyzed, and lyophilized (yield, 33 mg). The conjugate was then rechromatographed [yield, 17 mg] |
Antibodies | Mab BA4 |
Antibody type and class | IgM |
Assay System | Indirect immunofluorescence |
Cross-reactivity | This antibody cross-reacted with 2 serotypes- A and B. BA4 also showed some cross-reactions at a low dilution with B. dermatitidis and H. capsulatum and C. terreus |
Proposed epitopes | N\A |
IEDB Epitope | N/A |
Proposed Utility | MAb against an epitope shared by all four serotypes may have value for the detection of cryptococcal antigens in body fluids. This antibody also has potent opsonic activity |
Curator ID | AA + AS |
Date of Curation | 08-01-2010 |
References | PMC259921 |
PolysacDB ID | 1031 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | The GXM is a high-molecular-weight linear (1-->3)-α-D-mannan substituted with single (1-->2)-β-xylosyl and (1-->2)-β-glucuronosyl residues. 0 acetylation occurs on the C-6 of about half of the mannose residues. The molar ratio of xylose-mannose-glucuronic acid is 2:3:1 for serotype A |
BCSDB Structure | 130362 |
Proposed functions | The capsular glucuronoxylomannan (GXM) of C. neoformans is anantiphagocytic and tolerogenic polysaccharide and potentiates virulence |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Tetanus toxoid |
Conjugation Method | GXM was derivatized by the following two methods. (i) In method 1, ADH [adipic acid dihydrazide] was introduced into GXM by the activation of carboxyl groups with EDAC. GXM (5 mg/ml of 0.2 M NaCl) was derivatized with 0.5 M ADH and 0.1 M EDAC at pH 4.85 for 3.5 h at room temperature, using a pH Stat. After extensive dialysis against 0.2 M NaCl, the reaction mixture was passed through a 2B-CL Sepharose column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The fractions containing GXM were pooled and concentrated to the original volume. (ii) In method 2, ADH was introduced into GXM by the activation of hydroxyl groups with CNBr. GXM (5 mg/ml of 0.2 M NaCl) was activated with an equal weight of CNBr at pH 10.5 for 6 min at 4°C, using a pH Stat. An equal volume of 0.5 M NaHCO3 (pH 8.5) containing 0.5 M ADH was added. The reaction mixture was tumbled at 3 to 8°C for 18 to 20 h, dialyzed against 0.2 M NaCl, and passed through a 2B-CL Sepharose column (1.5 by 30 cm). The fractions containing GXM were pooled and concentrated to the original volume. The reaction mixture, containing equal concentrations (3.0 to 7.5 mg/ml) of GXM-AH (derivatized by either method) and TT or rEPA in 0.2 M NaCl, was brought to pH 5.6 with 0.05 N HCl, and 0.05 to 0.1 M EDAC was added; the pH was maintained at 5.6 in a pH Stat for 1 to 3 h at 4°C. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a Sepharose 2B-CL column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The void volume fractions containing the GXM and the protein were pooled and stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Mab 18B7 |
Antibody type and class | IgG1 |
Assay System | Invivo protection assay |
Cross-reactivity | This antibody cross-reacted with all 4 serotypes- A, B, C and D. |
Proposed epitopes | N\A |
IEDB Epitope | N/A |
Proposed Utility | This antibody opsonized Serotypes A and D and was shown to activate the complement pathway. This antibody is in pre-clinical development for treatment of Cryptococcus neoformans infections |
Curator ID | AA + AS |
Date of Curation | 09-01-2010 |
References | PMC105619 |
PolysacDB ID | 2617 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A linear α(1-->3)- linked mannan backbone singly substituted with non-reducing β(1-->2) xylose and β(1-->2) glucuronic acid side branches ; O-acetyl groups are present at C-6 of the mannosyl residues |
BCSDB Structure | 130362 |
Proposed functions | Antiphagocytic ; an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Pseudomonas aeruginosa exoprotein A (rEPA) |
Conjugation Method | GXM was derivatized by the following two methods. (i) In method 1, ADH [adipic acid dihydrazide] was introduced into GXM by the activation of carboxyl groups with EDAC. GXM (5 mg/ml of 0.2 M NaCl) was derivatized with 0.5 M ADH and 0.1 M EDAC at pH 4.85 for 3.5 h at room temperature, using a pH Stat. After extensive dialysis against 0.2 M NaCl, the reaction mixture was passed through a 2B-CL Sepharose column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The fractions containing GXM were pooled and concentrated to the original volume. (ii) In method 2, ADH was introduced into GXM by the activation of hydroxyl groups with CNBr. GXM (5 mg/ml of 0.2 M NaCl) was activated with an equal weight of CNBr at pH 10.5 for 6 min at 4°C, using a pH Stat. An equal volume of 0.5 M NaHCO3 (pH 8.5) containing 0.5 M ADH was added. The reaction mixture was tumbled at 3 to 8°C for 18 to 20 h, dialyzed against 0.2 M NaCl, and passed through a 2B-CL Sepharose column (1.5 by 30 cm). The fractions containing GXM were pooled and concentrated to the original volume. The reaction mixture, containing equal concentrations (3.0 to 7.5 mg/ml) of GXM-AH (derivatized by either method) and TT or rEPA in 0.2 M NaCl, was brought to pH 5.6 with 0.05 N HCl, and 0.05 to 0.1 M EDAC was added; the pH was maintained at 5.6 in a pH Stat for 1 to 3 h at 4°C. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a Sepharose 2B-CL column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The void volume fractions containing the GXM and the protein were pooled and stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Mab 4H9 |
Antibody type and class | IgM |
Assay System | ELISA |
Cross-reactivity | This antibody cross-reacted with Serotype A,B,C and D serotypes |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was used to decipher and differentiate the serum antibody response of autoimmune mice as compared to normal mice |
Curator ID | AA + AS |
Date of Curation | 21-07-2011 |
References | 10456888 |
PolysacDB ID | 2618 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A linear α(1-->3)- linked mannan backbone singly substituted with non-reducing β(1-->2) xylose and β(1-->2) glucuronic acid side branches ; O-acetyl groups are present at C-6 of the mannosyl residues |
BCSDB Structure | 130362 |
Proposed functions | Antiphagocytic ; an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Pseudomonas aeruginosa exoprotein A (rEPA) |
Conjugation Method | GXM was derivatized by the following two methods. (i) In method 1, ADH [adipic acid dihydrazide] was introduced into GXM by the activation of carboxyl groups with EDAC. GXM (5 mg/ml of 0.2 M NaCl) was derivatized with 0.5 M ADH and 0.1 M EDAC at pH 4.85 for 3.5 h at room temperature, using a pH Stat. After extensive dialysis against 0.2 M NaCl, the reaction mixture was passed through a 2B-CL Sepharose column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The fractions containing GXM were pooled and concentrated to the original volume. (ii) In method 2, ADH was introduced into GXM by the activation of hydroxyl groups with CNBr. GXM (5 mg/ml of 0.2 M NaCl) was activated with an equal weight of CNBr at pH 10.5 for 6 min at 4°C, using a pH Stat. An equal volume of 0.5 M NaHCO3 (pH 8.5) containing 0.5 M ADH was added. The reaction mixture was tumbled at 3 to 8°C for 18 to 20 h, dialyzed against 0.2 M NaCl, and passed through a 2B-CL Sepharose column (1.5 by 30 cm). The fractions containing GXM were pooled and concentrated to the original volume. The reaction mixture, containing equal concentrations (3.0 to 7.5 mg/ml) of GXM-AH (derivatized by either method) and TT or rEPA in 0.2 M NaCl, was brought to pH 5.6 with 0.05 N HCl, and 0.05 to 0.1 M EDAC was added; the pH was maintained at 5.6 in a pH Stat for 1 to 3 h at 4°C. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a Sepharose 2B-CL column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The void volume fractions containing the GXM and the protein were pooled and stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Mab 6C3.4 |
Antibody type and class | IgM |
Assay System | ELISA |
Cross-reactivity | This antibody cross-reacted with Serotype A,B,C and D serotypes |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was used to decipher and differentiate the serum antibody response of autoimmune mice as compared to normal mice |
Curator ID | AA + AS |
Date of Curation | 22-07-2011 |
References | 10456888 |
PolysacDB ID | 2619 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A linear α(1-->3)- linked mannan backbone singly substituted with non-reducing β(1-->2) xylose and β(1-->2) glucuronic acid side branches ; O-acetyl groups are present at C-6 of the mannosyl residues |
BCSDB Structure | 130362 |
Proposed functions | Antiphagocytic ; an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Pseudomonas aeruginosa exoprotein A (rEPA) |
Conjugation Method | GXM was derivatized by the following two methods. (i) In method 1, ADH [adipic acid dihydrazide] was introduced into GXM by the activation of carboxyl groups with EDAC. GXM (5 mg/ml of 0.2 M NaCl) was derivatized with 0.5 M ADH and 0.1 M EDAC at pH 4.85 for 3.5 h at room temperature, using a pH Stat. After extensive dialysis against 0.2 M NaCl, the reaction mixture was passed through a 2B-CL Sepharose column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The fractions containing GXM were pooled and concentrated to the original volume. (ii) In method 2, ADH was introduced into GXM by the activation of hydroxyl groups with CNBr. GXM (5 mg/ml of 0.2 M NaCl) was activated with an equal weight of CNBr at pH 10.5 for 6 min at 4°C, using a pH Stat. An equal volume of 0.5 M NaHCO3 (pH 8.5) containing 0.5 M ADH was added. The reaction mixture was tumbled at 3 to 8°C for 18 to 20 h, dialyzed against 0.2 M NaCl, and passed through a 2B-CL Sepharose column (1.5 by 30 cm). The fractions containing GXM were pooled and concentrated to the original volume. The reaction mixture, containing equal concentrations (3.0 to 7.5 mg/ml) of GXM-AH (derivatized by either method) and TT or rEPA in 0.2 M NaCl, was brought to pH 5.6 with 0.05 N HCl, and 0.05 to 0.1 M EDAC was added; the pH was maintained at 5.6 in a pH Stat for 1 to 3 h at 4°C. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a Sepharose 2B-CL column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The void volume fractions containing the GXM and the protein were pooled and stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Mab 6A5 |
Antibody type and class | IgG3 |
Assay System | ELISA |
Cross-reactivity | This antibody cross-reacted with Serotype A,B,C and D serotypes |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was used to decipher and differentiate the serum antibody response of autoimmune mice as compared to normal mice |
Curator ID | AA + AS |
Date of Curation | 22-07-2011 |
References | 10456888 |
PolysacDB ID | 2620 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A linear α(1-->3)- linked mannan backbone singly substituted with non-reducing β(1-->2) xylose and β(1-->2) glucuronic acid side branches ; O-acetyl groups are present at C-6 of the mannosyl residues |
BCSDB Structure | 130362 |
Proposed functions | Antiphagocytic ; an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Pseudomonas aeruginosa exoprotein A (rEPA) |
Conjugation Method | GXM was derivatized by the following two methods. (i) In method 1, ADH [adipic acid dihydrazide] was introduced into GXM by the activation of carboxyl groups with EDAC. GXM (5 mg/ml of 0.2 M NaCl) was derivatized with 0.5 M ADH and 0.1 M EDAC at pH 4.85 for 3.5 h at room temperature, using a pH Stat. After extensive dialysis against 0.2 M NaCl, the reaction mixture was passed through a 2B-CL Sepharose column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The fractions containing GXM were pooled and concentrated to the original volume. (ii) In method 2, ADH was introduced into GXM by the activation of hydroxyl groups with CNBr. GXM (5 mg/ml of 0.2 M NaCl) was activated with an equal weight of CNBr at pH 10.5 for 6 min at 4°C, using a pH Stat. An equal volume of 0.5 M NaHCO3 (pH 8.5) containing 0.5 M ADH was added. The reaction mixture was tumbled at 3 to 8°C for 18 to 20 h, dialyzed against 0.2 M NaCl, and passed through a 2B-CL Sepharose column (1.5 by 30 cm). The fractions containing GXM were pooled and concentrated to the original volume. The reaction mixture, containing equal concentrations (3.0 to 7.5 mg/ml) of GXM-AH (derivatized by either method) and TT or rEPA in 0.2 M NaCl, was brought to pH 5.6 with 0.05 N HCl, and 0.05 to 0.1 M EDAC was added; the pH was maintained at 5.6 in a pH Stat for 1 to 3 h at 4°C. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a Sepharose 2B-CL column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The void volume fractions containing the GXM and the protein were pooled and stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Mab 9A12 |
Antibody type and class | IgG3 |
Assay System | ELISA |
Cross-reactivity | This antibody cross-reacted with Serotype A,B,C and D serotypes |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was used to decipher and differentiate the serum antibody response of autoimmune mice as compared to normal mice |
Curator ID | AA + AS |
Date of Curation | 22-07-2011 |
References | 10456888 |
PolysacDB ID | 2621 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A linear α(1-->3)- linked mannan backbone singly substituted with non-reducing β(1-->2) xylose and β(1-->2) glucuronic acid side branches ; O-acetyl groups are present at C-6 of the mannosyl residues |
BCSDB Structure | 130362 |
Proposed functions | Antiphagocytic ; an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Pseudomonas aeruginosa exoprotein A (rEPA) |
Conjugation Method | GXM was derivatized by the following two methods. (i) In method 1, ADH [adipic acid dihydrazide] was introduced into GXM by the activation of carboxyl groups with EDAC. GXM (5 mg/ml of 0.2 M NaCl) was derivatized with 0.5 M ADH and 0.1 M EDAC at pH 4.85 for 3.5 h at room temperature, using a pH Stat. After extensive dialysis against 0.2 M NaCl, the reaction mixture was passed through a 2B-CL Sepharose column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The fractions containing GXM were pooled and concentrated to the original volume. (ii) In method 2, ADH was introduced into GXM by the activation of hydroxyl groups with CNBr. GXM (5 mg/ml of 0.2 M NaCl) was activated with an equal weight of CNBr at pH 10.5 for 6 min at 4°C, using a pH Stat. An equal volume of 0.5 M NaHCO3 (pH 8.5) containing 0.5 M ADH was added. The reaction mixture was tumbled at 3 to 8°C for 18 to 20 h, dialyzed against 0.2 M NaCl, and passed through a 2B-CL Sepharose column (1.5 by 30 cm). The fractions containing GXM were pooled and concentrated to the original volume. The reaction mixture, containing equal concentrations (3.0 to 7.5 mg/ml) of GXM-AH (derivatized by either method) and TT or rEPA in 0.2 M NaCl, was brought to pH 5.6 with 0.05 N HCl, and 0.05 to 0.1 M EDAC was added; the pH was maintained at 5.6 in a pH Stat for 1 to 3 h at 4°C. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a Sepharose 2B-CL column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The void volume fractions containing the GXM and the protein were pooled and stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Mab A2F12 |
Antibody type and class | IgG3 |
Assay System | ELISA |
Cross-reactivity | This antibody cross-reacted with Serotype A,B,C and D serotypes |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was used to decipher and differentiate the serum antibody response of autoimmune mice as compared to normal mice |
Curator ID | AA + AS |
Date of Curation | 23-07-2011 |
References | 10456888 |
PolysacDB ID | 2622 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A linear α(1-->3)- linked mannan backbone singly substituted with non-reducing β(1-->2) xylose and β(1-->2) glucuronic acid side branches ; O-acetyl groups are present at C-6 of the mannosyl residues |
BCSDB Structure | 130362 |
Proposed functions | Antiphagocytic ; an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Pseudomonas aeruginosa exoprotein A (rEPA) |
Conjugation Method | GXM was derivatized by the following two methods. (i) In method 1, ADH [adipic acid dihydrazide] was introduced into GXM by the activation of carboxyl groups with EDAC. GXM (5 mg/ml of 0.2 M NaCl) was derivatized with 0.5 M ADH and 0.1 M EDAC at pH 4.85 for 3.5 h at room temperature, using a pH Stat. After extensive dialysis against 0.2 M NaCl, the reaction mixture was passed through a 2B-CL Sepharose column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The fractions containing GXM were pooled and concentrated to the original volume. (ii) In method 2, ADH was introduced into GXM by the activation of hydroxyl groups with CNBr. GXM (5 mg/ml of 0.2 M NaCl) was activated with an equal weight of CNBr at pH 10.5 for 6 min at 4°C, using a pH Stat. An equal volume of 0.5 M NaHCO3 (pH 8.5) containing 0.5 M ADH was added. The reaction mixture was tumbled at 3 to 8°C for 18 to 20 h, dialyzed against 0.2 M NaCl, and passed through a 2B-CL Sepharose column (1.5 by 30 cm). The fractions containing GXM were pooled and concentrated to the original volume. The reaction mixture, containing equal concentrations (3.0 to 7.5 mg/ml) of GXM-AH (derivatized by either method) and TT or rEPA in 0.2 M NaCl, was brought to pH 5.6 with 0.05 N HCl, and 0.05 to 0.1 M EDAC was added; the pH was maintained at 5.6 in a pH Stat for 1 to 3 h at 4°C. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a Sepharose 2B-CL column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The void volume fractions containing the GXM and the protein were pooled and stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Mab 6C3.3 |
Antibody type and class | IgG1 |
Assay System | ELISA |
Cross-reactivity | This antibody cross-reacted with Serotype A,B,C and D serotypes |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was used to decipher and differentiate the serum antibody response of autoimmune mice as compared to normal mice |
Curator ID | AA + AS |
Date of Curation | 23-07-2011 |
References | 10456888 |
PolysacDB ID | 2623 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A linear α(1-->3)- linked mannan backbone singly substituted with non-reducing β(1-->2) xylose and β(1-->2) glucuronic acid side branches ; O-acetyl groups are present at C-6 of the mannosyl residues |
BCSDB Structure | 130362 |
Proposed functions | Antiphagocytic ; an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Pseudomonas aeruginosa exoprotein A (rEPA) |
Conjugation Method | GXM was derivatized by the following two methods. (i) In method 1, ADH [adipic acid dihydrazide] was introduced into GXM by the activation of carboxyl groups with EDAC. GXM (5 mg/ml of 0.2 M NaCl) was derivatized with 0.5 M ADH and 0.1 M EDAC at pH 4.85 for 3.5 h at room temperature, using a pH Stat. After extensive dialysis against 0.2 M NaCl, the reaction mixture was passed through a 2B-CL Sepharose column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The fractions containing GXM were pooled and concentrated to the original volume. (ii) In method 2, ADH was introduced into GXM by the activation of hydroxyl groups with CNBr. GXM (5 mg/ml of 0.2 M NaCl) was activated with an equal weight of CNBr at pH 10.5 for 6 min at 4°C, using a pH Stat. An equal volume of 0.5 M NaHCO3 (pH 8.5) containing 0.5 M ADH was added. The reaction mixture was tumbled at 3 to 8°C for 18 to 20 h, dialyzed against 0.2 M NaCl, and passed through a 2B-CL Sepharose column (1.5 by 30 cm). The fractions containing GXM were pooled and concentrated to the original volume. The reaction mixture, containing equal concentrations (3.0 to 7.5 mg/ml) of GXM-AH (derivatized by either method) and TT or rEPA in 0.2 M NaCl, was brought to pH 5.6 with 0.05 N HCl, and 0.05 to 0.1 M EDAC was added; the pH was maintained at 5.6 in a pH Stat for 1 to 3 h at 4°C. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a Sepharose 2B-CL column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The void volume fractions containing the GXM and the protein were pooled and stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Mab IG5 |
Antibody type and class | IgG2a |
Assay System | ELISA |
Cross-reactivity | This antibody cross-reacted with Serotype A,B,C and D serotypes |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was used to decipher and differentiate the serum antibody response of autoimmune mice as compared to normal mice |
Curator ID | AA + AS |
Date of Curation | 24-07-2011 |
References | 10456888 |
PolysacDB ID | 2624 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A linear α(1-->3)- linked mannan backbone singly substituted with non-reducing β(1-->2) xylose and β(1-->2) glucuronic acid side branches ; O-acetyl groups are present at C-6 of the mannosyl residues |
BCSDB Structure | 130362 |
Proposed functions | Antiphagocytic ; an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Pseudomonas aeruginosa exoprotein A (rEPA) |
Conjugation Method | GXM was derivatized by the following two methods. (i) In method 1, ADH [adipic acid dihydrazide] was introduced into GXM by the activation of carboxyl groups with EDAC. GXM (5 mg/ml of 0.2 M NaCl) was derivatized with 0.5 M ADH and 0.1 M EDAC at pH 4.85 for 3.5 h at room temperature, using a pH Stat. After extensive dialysis against 0.2 M NaCl, the reaction mixture was passed through a 2B-CL Sepharose column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The fractions containing GXM were pooled and concentrated to the original volume. (ii) In method 2, ADH was introduced into GXM by the activation of hydroxyl groups with CNBr. GXM (5 mg/ml of 0.2 M NaCl) was activated with an equal weight of CNBr at pH 10.5 for 6 min at 4°C, using a pH Stat. An equal volume of 0.5 M NaHCO3 (pH 8.5) containing 0.5 M ADH was added. The reaction mixture was tumbled at 3 to 8°C for 18 to 20 h, dialyzed against 0.2 M NaCl, and passed through a 2B-CL Sepharose column (1.5 by 30 cm). The fractions containing GXM were pooled and concentrated to the original volume. The reaction mixture, containing equal concentrations (3.0 to 7.5 mg/ml) of GXM-AH (derivatized by either method) and TT or rEPA in 0.2 M NaCl, was brought to pH 5.6 with 0.05 N HCl, and 0.05 to 0.1 M EDAC was added; the pH was maintained at 5.6 in a pH Stat for 1 to 3 h at 4°C. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a Sepharose 2B-CL column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The void volume fractions containing the GXM and the protein were pooled and stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Mab 7f8 |
Antibody type and class | IgG2a |
Assay System | ELISA |
Cross-reactivity | This antibody cross-reacted with Serotype A,B,C and D serotypes |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was used to decipher and differentiate the serum antibody response of autoimmune mice as compared to normal mice |
Curator ID | AA + AS |
Date of Curation | 24-07-2011 |
References | 10456888 |
PolysacDB ID | 2625 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A linear α(1-->3)- linked mannan backbone singly substituted with non-reducing β(1-->2) xylose and β(1-->2) glucuronic acid side branches ; O-acetyl groups are present at C-6 of the mannosyl residues |
BCSDB Structure | 130362 |
Proposed functions | Antiphagocytic ; an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Pseudomonas aeruginosa exoprotein A (rEPA) |
Conjugation Method | GXM was derivatized by the following two methods. (i) In method 1, ADH [adipic acid dihydrazide] was introduced into GXM by the activation of carboxyl groups with EDAC. GXM (5 mg/ml of 0.2 M NaCl) was derivatized with 0.5 M ADH and 0.1 M EDAC at pH 4.85 for 3.5 h at room temperature, using a pH Stat. After extensive dialysis against 0.2 M NaCl, the reaction mixture was passed through a 2B-CL Sepharose column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The fractions containing GXM were pooled and concentrated to the original volume. (ii) In method 2, ADH was introduced into GXM by the activation of hydroxyl groups with CNBr. GXM (5 mg/ml of 0.2 M NaCl) was activated with an equal weight of CNBr at pH 10.5 for 6 min at 4°C, using a pH Stat. An equal volume of 0.5 M NaHCO3 (pH 8.5) containing 0.5 M ADH was added. The reaction mixture was tumbled at 3 to 8°C for 18 to 20 h, dialyzed against 0.2 M NaCl, and passed through a 2B-CL Sepharose column (1.5 by 30 cm). The fractions containing GXM were pooled and concentrated to the original volume. The reaction mixture, containing equal concentrations (3.0 to 7.5 mg/ml) of GXM-AH (derivatized by either method) and TT or rEPA in 0.2 M NaCl, was brought to pH 5.6 with 0.05 N HCl, and 0.05 to 0.1 M EDAC was added; the pH was maintained at 5.6 in a pH Stat for 1 to 3 h at 4°C. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a Sepharose 2B-CL column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The void volume fractions containing the GXM and the protein were pooled and stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Mab 12g6 |
Antibody type and class | IgG2a |
Assay System | ELISA |
Cross-reactivity | This antibody cross-reacted with Serotype A,B,C and D serotypes |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was used to decipher and differentiate the serum antibody response of autoimmune mice as compared to normal mice |
Curator ID | AA + AS |
Date of Curation | 24-07-2011 |
References | 10456888 |
PolysacDB ID | 2626 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A linear α(1-->3)- linked mannan backbone singly substituted with non-reducing β(1-->2) xylose and β(1-->2) glucuronic acid side branches ; O-acetyl groups are present at C-6 of the mannosyl residues |
BCSDB Structure | 130362 |
Proposed functions | Antiphagocytic ; an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Pseudomonas aeruginosa exoprotein A (rEPA) |
Conjugation Method | GXM was derivatized by the following two methods. (i) In method 1, ADH [adipic acid dihydrazide] was introduced into GXM by the activation of carboxyl groups with EDAC. GXM (5 mg/ml of 0.2 M NaCl) was derivatized with 0.5 M ADH and 0.1 M EDAC at pH 4.85 for 3.5 h at room temperature, using a pH Stat. After extensive dialysis against 0.2 M NaCl, the reaction mixture was passed through a 2B-CL Sepharose column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The fractions containing GXM were pooled and concentrated to the original volume. (ii) In method 2, ADH was introduced into GXM by the activation of hydroxyl groups with CNBr. GXM (5 mg/ml of 0.2 M NaCl) was activated with an equal weight of CNBr at pH 10.5 for 6 min at 4°C, using a pH Stat. An equal volume of 0.5 M NaHCO3 (pH 8.5) containing 0.5 M ADH was added. The reaction mixture was tumbled at 3 to 8°C for 18 to 20 h, dialyzed against 0.2 M NaCl, and passed through a 2B-CL Sepharose column (1.5 by 30 cm). The fractions containing GXM were pooled and concentrated to the original volume. The reaction mixture, containing equal concentrations (3.0 to 7.5 mg/ml) of GXM-AH (derivatized by either method) and TT or rEPA in 0.2 M NaCl, was brought to pH 5.6 with 0.05 N HCl, and 0.05 to 0.1 M EDAC was added; the pH was maintained at 5.6 in a pH Stat for 1 to 3 h at 4°C. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a Sepharose 2B-CL column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The void volume fractions containing the GXM and the protein were pooled and stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Mab 12A1.4 |
Antibody type and class | IgG2b |
Assay System | ELISA |
Cross-reactivity | This antibody cross-reacted with Serotype A,B,C and D serotypes |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was used to decipher and differentiate the serum antibody response of autoimmune mice as compared to normal mice |
Curator ID | AA + AS |
Date of Curation | 24-07-2011 |
References | 10456888 |
PolysacDB ID | 2627 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A linear α(1-->3)- linked mannan backbone singly substituted with non-reducing β(1-->2) xylose and β(1-->2) glucuronic acid side branches ; O-acetyl groups are present at C-6 of the mannosyl residues |
BCSDB Structure | 130362 |
Proposed functions | Antiphagocytic ; an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Pseudomonas aeruginosa exoprotein A (rEPA) |
Conjugation Method | GXM was derivatized by the following two methods. (i) In method 1, ADH [adipic acid dihydrazide] was introduced into GXM by the activation of carboxyl groups with EDAC. GXM (5 mg/ml of 0.2 M NaCl) was derivatized with 0.5 M ADH and 0.1 M EDAC at pH 4.85 for 3.5 h at room temperature, using a pH Stat. After extensive dialysis against 0.2 M NaCl, the reaction mixture was passed through a 2B-CL Sepharose column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The fractions containing GXM were pooled and concentrated to the original volume. (ii) In method 2, ADH was introduced into GXM by the activation of hydroxyl groups with CNBr. GXM (5 mg/ml of 0.2 M NaCl) was activated with an equal weight of CNBr at pH 10.5 for 6 min at 4°C, using a pH Stat. An equal volume of 0.5 M NaHCO3 (pH 8.5) containing 0.5 M ADH was added. The reaction mixture was tumbled at 3 to 8°C for 18 to 20 h, dialyzed against 0.2 M NaCl, and passed through a 2B-CL Sepharose column (1.5 by 30 cm). The fractions containing GXM were pooled and concentrated to the original volume. The reaction mixture, containing equal concentrations (3.0 to 7.5 mg/ml) of GXM-AH (derivatized by either method) and TT or rEPA in 0.2 M NaCl, was brought to pH 5.6 with 0.05 N HCl, and 0.05 to 0.1 M EDAC was added; the pH was maintained at 5.6 in a pH Stat for 1 to 3 h at 4°C. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a Sepharose 2B-CL column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The void volume fractions containing the GXM and the protein were pooled and stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Mab 15E6 |
Antibody type and class | IgG2b |
Assay System | ELISA |
Cross-reactivity | This antibody cross-reacted with Serotype A,B,C and D serotypes |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was used to decipher and differentiate the serum antibody response of autoimmune mice as compared to normal mice |
Curator ID | AA + AS |
Date of Curation | 24-07-2011 |
References | 10456888 |
PolysacDB ID | 2628 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A linear α(1-->3)- linked mannan backbone singly substituted with non-reducing β(1-->2) xylose and β(1-->2) glucuronic acid side branches ; O-acetyl groups are present at C-6 of the mannosyl residues |
BCSDB Structure | 130362 |
Proposed functions | Antiphagocytic ; an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Pseudomonas aeruginosa exoprotein A (rEPA) |
Conjugation Method | GXM was derivatized by the following two methods. (i) In method 1, ADH [adipic acid dihydrazide] was introduced into GXM by the activation of carboxyl groups with EDAC. GXM (5 mg/ml of 0.2 M NaCl) was derivatized with 0.5 M ADH and 0.1 M EDAC at pH 4.85 for 3.5 h at room temperature, using a pH Stat. After extensive dialysis against 0.2 M NaCl, the reaction mixture was passed through a 2B-CL Sepharose column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The fractions containing GXM were pooled and concentrated to the original volume. (ii) In method 2, ADH was introduced into GXM by the activation of hydroxyl groups with CNBr. GXM (5 mg/ml of 0.2 M NaCl) was activated with an equal weight of CNBr at pH 10.5 for 6 min at 4°C, using a pH Stat. An equal volume of 0.5 M NaHCO3 (pH 8.5) containing 0.5 M ADH was added. The reaction mixture was tumbled at 3 to 8°C for 18 to 20 h, dialyzed against 0.2 M NaCl, and passed through a 2B-CL Sepharose column (1.5 by 30 cm). The fractions containing GXM were pooled and concentrated to the original volume. The reaction mixture, containing equal concentrations (3.0 to 7.5 mg/ml) of GXM-AH (derivatized by either method) and TT or rEPA in 0.2 M NaCl, was brought to pH 5.6 with 0.05 N HCl, and 0.05 to 0.1 M EDAC was added; the pH was maintained at 5.6 in a pH Stat for 1 to 3 h at 4°C. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a Sepharose 2B-CL column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The void volume fractions containing the GXM and the protein were pooled and stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Mab 14F8 |
Antibody type and class | IgG2b |
Assay System | ELISA |
Cross-reactivity | This antibody cross-reacted with Serotype A,B,C and D serotypes |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was used to decipher and differentiate the serum antibody response of autoimmune mice as compared to normal mice |
Curator ID | AA + AS |
Date of Curation | 25-07-2011 |
References | 10456888 |
PolysacDB ID | 2629 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A linear α(1-->3)- linked mannan backbone singly substituted with non-reducing β(1-->2) xylose and β(1-->2) glucuronic acid side branches ; O-acetyl groups are present at C-6 of the mannosyl residues |
BCSDB Structure | 130362 |
Proposed functions | Antiphagocytic ; an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Pseudomonas aeruginosa exoprotein A (rEPA) |
Conjugation Method | GXM was derivatized by the following two methods. (i) In method 1, ADH [adipic acid dihydrazide] was introduced into GXM by the activation of carboxyl groups with EDAC. GXM (5 mg/ml of 0.2 M NaCl) was derivatized with 0.5 M ADH and 0.1 M EDAC at pH 4.85 for 3.5 h at room temperature, using a pH Stat. After extensive dialysis against 0.2 M NaCl, the reaction mixture was passed through a 2B-CL Sepharose column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The fractions containing GXM were pooled and concentrated to the original volume. (ii) In method 2, ADH was introduced into GXM by the activation of hydroxyl groups with CNBr. GXM (5 mg/ml of 0.2 M NaCl) was activated with an equal weight of CNBr at pH 10.5 for 6 min at 4°C, using a pH Stat. An equal volume of 0.5 M NaHCO3 (pH 8.5) containing 0.5 M ADH was added. The reaction mixture was tumbled at 3 to 8°C for 18 to 20 h, dialyzed against 0.2 M NaCl, and passed through a 2B-CL Sepharose column (1.5 by 30 cm). The fractions containing GXM were pooled and concentrated to the original volume. The reaction mixture, containing equal concentrations (3.0 to 7.5 mg/ml) of GXM-AH (derivatized by either method) and TT or rEPA in 0.2 M NaCl, was brought to pH 5.6 with 0.05 N HCl, and 0.05 to 0.1 M EDAC was added; the pH was maintained at 5.6 in a pH Stat for 1 to 3 h at 4°C. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a Sepharose 2B-CL column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The void volume fractions containing the GXM and the protein were pooled and stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Mab 2G3 |
Antibody type and class | IgA |
Assay System | ELISA |
Cross-reactivity | This antibody cross-reacted with Serotype A,B,C and D serotypes |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was used to decipher and differentiate the serum antibody response of autoimmune mice as compared to normal mice |
Curator ID | AA + AS |
Date of Curation | 25-07-2011 |
References | 10456888 |
PolysacDB ID | 2630 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A linear α(1-->3)- linked mannan backbone singly substituted with non-reducing β(1-->2) xylose and β(1-->2) glucuronic acid side branches ; O-acetyl groups are present at C-6 of the mannosyl residues |
BCSDB Structure | 130362 |
Proposed functions | Antiphagocytic ; an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Pseudomonas aeruginosa exoprotein A (rEPA) |
Conjugation Method | GXM was derivatized by the following two methods. (i) In method 1, ADH [adipic acid dihydrazide] was introduced into GXM by the activation of carboxyl groups with EDAC. GXM (5 mg/ml of 0.2 M NaCl) was derivatized with 0.5 M ADH and 0.1 M EDAC at pH 4.85 for 3.5 h at room temperature, using a pH Stat. After extensive dialysis against 0.2 M NaCl, the reaction mixture was passed through a 2B-CL Sepharose column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The fractions containing GXM were pooled and concentrated to the original volume. (ii) In method 2, ADH was introduced into GXM by the activation of hydroxyl groups with CNBr. GXM (5 mg/ml of 0.2 M NaCl) was activated with an equal weight of CNBr at pH 10.5 for 6 min at 4°C, using a pH Stat. An equal volume of 0.5 M NaHCO3 (pH 8.5) containing 0.5 M ADH was added. The reaction mixture was tumbled at 3 to 8°C for 18 to 20 h, dialyzed against 0.2 M NaCl, and passed through a 2B-CL Sepharose column (1.5 by 30 cm). The fractions containing GXM were pooled and concentrated to the original volume. The reaction mixture, containing equal concentrations (3.0 to 7.5 mg/ml) of GXM-AH (derivatized by either method) and TT or rEPA in 0.2 M NaCl, was brought to pH 5.6 with 0.05 N HCl, and 0.05 to 0.1 M EDAC was added; the pH was maintained at 5.6 in a pH Stat for 1 to 3 h at 4°C. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a Sepharose 2B-CL column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The void volume fractions containing the GXM and the protein were pooled and stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Mab 13C8 |
Antibody type and class | IgA |
Assay System | ELISA |
Cross-reactivity | This antibody cross-reacted with Serotype A,B,C and D serotypes |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was used to decipher and differentiate the serum antibody response of autoimmune mice as compared to normal mice |
Curator ID | AA + AS |
Date of Curation | 25-07-2011 |
References | 10456888 |
PolysacDB ID | 2631 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A linear α(1-->3)- linked mannan backbone singly substituted with non-reducing β(1-->2) xylose and β(1-->2) glucuronic acid side branches ; O-acetyl groups are present at C-6 of the mannosyl residues |
BCSDB Structure | 130362 |
Proposed functions | Antiphagocytic ; an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Pseudomonas aeruginosa exoprotein A (rEPA) |
Conjugation Method | GXM was derivatized by the following two methods. (i) In method 1, ADH [adipic acid dihydrazide] was introduced into GXM by the activation of carboxyl groups with EDAC. GXM (5 mg/ml of 0.2 M NaCl) was derivatized with 0.5 M ADH and 0.1 M EDAC at pH 4.85 for 3.5 h at room temperature, using a pH Stat. After extensive dialysis against 0.2 M NaCl, the reaction mixture was passed through a 2B-CL Sepharose column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The fractions containing GXM were pooled and concentrated to the original volume. (ii) In method 2, ADH was introduced into GXM by the activation of hydroxyl groups with CNBr. GXM (5 mg/ml of 0.2 M NaCl) was activated with an equal weight of CNBr at pH 10.5 for 6 min at 4°C, using a pH Stat. An equal volume of 0.5 M NaHCO3 (pH 8.5) containing 0.5 M ADH was added. The reaction mixture was tumbled at 3 to 8°C for 18 to 20 h, dialyzed against 0.2 M NaCl, and passed through a 2B-CL Sepharose column (1.5 by 30 cm). The fractions containing GXM were pooled and concentrated to the original volume. The reaction mixture, containing equal concentrations (3.0 to 7.5 mg/ml) of GXM-AH (derivatized by either method) and TT or rEPA in 0.2 M NaCl, was brought to pH 5.6 with 0.05 N HCl, and 0.05 to 0.1 M EDAC was added; the pH was maintained at 5.6 in a pH Stat for 1 to 3 h at 4°C. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a Sepharose 2B-CL column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The void volume fractions containing the GXM and the protein were pooled and stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Mab 16 |
Antibody type and class | IgG1 |
Assay System | ELISA |
Cross-reactivity | This antibody cross-reacted with Serotype A,B,C and D serotypes |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was used to decipher and differentiate the serum antibody response of autoimmune mice as compared to normal mice |
Curator ID | AA + AS |
Date of Curation | 26-07-2011 |
References | 10456888 |
PolysacDB ID | 2632 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A linear α(1-->3)- linked mannan backbone singly substituted with non-reducing β(1-->2) xylose and β(1-->2) glucuronic acid side branches ; O-acetyl groups are present at C-6 of the mannosyl residues |
BCSDB Structure | 130362 |
Proposed functions | Antiphagocytic ; an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Pseudomonas aeruginosa exoprotein A (rEPA) |
Conjugation Method | GXM was derivatized by the following two methods. (i) In method 1, ADH [adipic acid dihydrazide] was introduced into GXM by the activation of carboxyl groups with EDAC. GXM (5 mg/ml of 0.2 M NaCl) was derivatized with 0.5 M ADH and 0.1 M EDAC at pH 4.85 for 3.5 h at room temperature, using a pH Stat. After extensive dialysis against 0.2 M NaCl, the reaction mixture was passed through a 2B-CL Sepharose column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The fractions containing GXM were pooled and concentrated to the original volume. (ii) In method 2, ADH was introduced into GXM by the activation of hydroxyl groups with CNBr. GXM (5 mg/ml of 0.2 M NaCl) was activated with an equal weight of CNBr at pH 10.5 for 6 min at 4°C, using a pH Stat. An equal volume of 0.5 M NaHCO3 (pH 8.5) containing 0.5 M ADH was added. The reaction mixture was tumbled at 3 to 8°C for 18 to 20 h, dialyzed against 0.2 M NaCl, and passed through a 2B-CL Sepharose column (1.5 by 30 cm). The fractions containing GXM were pooled and concentrated to the original volume. The reaction mixture, containing equal concentrations (3.0 to 7.5 mg/ml) of GXM-AH (derivatized by either method) and TT or rEPA in 0.2 M NaCl, was brought to pH 5.6 with 0.05 N HCl, and 0.05 to 0.1 M EDAC was added; the pH was maintained at 5.6 in a pH Stat for 1 to 3 h at 4°C. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a Sepharose 2B-CL column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The void volume fractions containing the GXM and the protein were pooled and stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Mab 23 |
Antibody type and class | IgG1 |
Assay System | ELISA |
Cross-reactivity | This antibody cross-reacted with Serotype A,B,C and D serotypes |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was used to decipher and differentiate the serum antibody response of autoimmune mice as compared to normal mice |
Curator ID | AA + AS |
Date of Curation | 26-07-2011 |
References | 10456888 |
PolysacDB ID | 2633 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A linear α(1-->3)- linked mannan backbone singly substituted with non-reducing β(1-->2) xylose and β(1-->2) glucuronic acid side branches ; O-acetyl groups are present at C-6 of the mannosyl residues |
BCSDB Structure | 130362 |
Proposed functions | Antiphagocytic ; an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Pseudomonas aeruginosa exoprotein A (rEPA) |
Conjugation Method | GXM was derivatized by the following two methods. (i) In method 1, ADH [adipic acid dihydrazide] was introduced into GXM by the activation of carboxyl groups with EDAC. GXM (5 mg/ml of 0.2 M NaCl) was derivatized with 0.5 M ADH and 0.1 M EDAC at pH 4.85 for 3.5 h at room temperature, using a pH Stat. After extensive dialysis against 0.2 M NaCl, the reaction mixture was passed through a 2B-CL Sepharose column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The fractions containing GXM were pooled and concentrated to the original volume. (ii) In method 2, ADH was introduced into GXM by the activation of hydroxyl groups with CNBr. GXM (5 mg/ml of 0.2 M NaCl) was activated with an equal weight of CNBr at pH 10.5 for 6 min at 4°C, using a pH Stat. An equal volume of 0.5 M NaHCO3 (pH 8.5) containing 0.5 M ADH was added. The reaction mixture was tumbled at 3 to 8°C for 18 to 20 h, dialyzed against 0.2 M NaCl, and passed through a 2B-CL Sepharose column (1.5 by 30 cm). The fractions containing GXM were pooled and concentrated to the original volume. The reaction mixture, containing equal concentrations (3.0 to 7.5 mg/ml) of GXM-AH (derivatized by either method) and TT or rEPA in 0.2 M NaCl, was brought to pH 5.6 with 0.05 N HCl, and 0.05 to 0.1 M EDAC was added; the pH was maintained at 5.6 in a pH Stat for 1 to 3 h at 4°C. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a Sepharose 2B-CL column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The void volume fractions containing the GXM and the protein were pooled and stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Mab 25 |
Antibody type and class | IgG1 |
Assay System | ELISA |
Cross-reactivity | This antibody cross-reacted with Serotype A,B,C and D serotypes |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was used to decipher and differentiate the serum antibody response of autoimmune mice as compared to normal mice |
Curator ID | AA + AS |
Date of Curation | 26-07-2011 |
References | 10456888 |
PolysacDB ID | 2634 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A linear α(1-->3)- linked mannan backbone singly substituted with non-reducing β(1-->2) xylose and β(1-->2) glucuronic acid side branches ; O-acetyl groups are present at C-6 of the mannosyl residues |
BCSDB Structure | 130362 |
Proposed functions | Antiphagocytic ; an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Pseudomonas aeruginosa exoprotein A (rEPA) |
Conjugation Method | GXM was derivatized by the following two methods. (i) In method 1, ADH [adipic acid dihydrazide] was introduced into GXM by the activation of carboxyl groups with EDAC. GXM (5 mg/ml of 0.2 M NaCl) was derivatized with 0.5 M ADH and 0.1 M EDAC at pH 4.85 for 3.5 h at room temperature, using a pH Stat. After extensive dialysis against 0.2 M NaCl, the reaction mixture was passed through a 2B-CL Sepharose column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The fractions containing GXM were pooled and concentrated to the original volume. (ii) In method 2, ADH was introduced into GXM by the activation of hydroxyl groups with CNBr. GXM (5 mg/ml of 0.2 M NaCl) was activated with an equal weight of CNBr at pH 10.5 for 6 min at 4°C, using a pH Stat. An equal volume of 0.5 M NaHCO3 (pH 8.5) containing 0.5 M ADH was added. The reaction mixture was tumbled at 3 to 8°C for 18 to 20 h, dialyzed against 0.2 M NaCl, and passed through a 2B-CL Sepharose column (1.5 by 30 cm). The fractions containing GXM were pooled and concentrated to the original volume. The reaction mixture, containing equal concentrations (3.0 to 7.5 mg/ml) of GXM-AH (derivatized by either method) and TT or rEPA in 0.2 M NaCl, was brought to pH 5.6 with 0.05 N HCl, and 0.05 to 0.1 M EDAC was added; the pH was maintained at 5.6 in a pH Stat for 1 to 3 h at 4°C. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a Sepharose 2B-CL column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The void volume fractions containing the GXM and the protein were pooled and stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Mab 29 |
Antibody type and class | IgG1 |
Assay System | ELISA |
Cross-reactivity | This antibody cross-reacted with Serotype A,B,C and D serotypes |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was used to decipher and differentiate the serum antibody response of autoimmune mice as compared to normal mice |
Curator ID | AA + AS |
Date of Curation | 27-07-2011 |
References | 10456888 |
PolysacDB ID | 2635 |
Carbohydrate Name | Glucurunoxylomannan (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Cryptococcus neoformans (NCBI Taxonomy) (Drugpedia) |
Basic Structure | A linear α(1-->3)- linked mannan backbone singly substituted with non-reducing β(1-->2) xylose and β(1-->2) glucuronic acid side branches ; O-acetyl groups are present at C-6 of the mannosyl residues |
BCSDB Structure | 130362 |
Proposed functions | Antiphagocytic ; an important virulence factor |
Antigenic Nature used to produce antibodies | Glycoconjugates |
Carrier Name | Tetanus toxoid |
Conjugation Method | GXM was derivatized by the following two methods. (i) In method 1, ADH [adipic acid dihydrazide] was introduced into GXM by the activation of carboxyl groups with EDAC. GXM (5 mg/ml of 0.2 M NaCl) was derivatized with 0.5 M ADH and 0.1 M EDAC at pH 4.85 for 3.5 h at room temperature, using a pH Stat. After extensive dialysis against 0.2 M NaCl, the reaction mixture was passed through a 2B-CL Sepharose column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The fractions containing GXM were pooled and concentrated to the original volume. (ii) In method 2, ADH was introduced into GXM by the activation of hydroxyl groups with CNBr. GXM (5 mg/ml of 0.2 M NaCl) was activated with an equal weight of CNBr at pH 10.5 for 6 min at 4°C, using a pH Stat. An equal volume of 0.5 M NaHCO3 (pH 8.5) containing 0.5 M ADH was added. The reaction mixture was tumbled at 3 to 8°C for 18 to 20 h, dialyzed against 0.2 M NaCl, and passed through a 2B-CL Sepharose column (1.5 by 30 cm). The fractions containing GXM were pooled and concentrated to the original volume. The reaction mixture, containing equal concentrations (3.0 to 7.5 mg/ml) of GXM-AH (derivatized by either method) and TT or rEPA in 0.2 M NaCl, was brought to pH 5.6 with 0.05 N HCl, and 0.05 to 0.1 M EDAC was added; the pH was maintained at 5.6 in a pH Stat for 1 to 3 h at 4°C. The reaction mixture was dialyzed against 0.2 M NaCl at 3 to 8°C and passed through a Sepharose 2B-CL column (1.5 by 30 cm) equilibrated in 0.2 M NaCl. The void volume fractions containing the GXM and the protein were pooled and stored in 0.01% thimerosal at 3 to 8°C |
Antibodies | Mab 12A1 |
Antibody type and class | IgM |
Assay System | ELISA |
Cross-reactivity | This antibody cross-reacted with Serotype A,B,C and D serotypes |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This antibody was used to decipher and differentiate the serum antibody response of autoimmune mice as compared to normal mice |
Curator ID | AA + AS |
Date of Curation | 27-07-2011 |
References | 10456888 |
Bioinformatics Centre, Institute of Microbial Technology, Sec - 39A, Chandigarh, India - 160036 |